Home / Europe / Ukraine / Life Sciences & Healthcare
volvox colony bright field microscope magnification 40x

Life Sciences & Healthcare

We work with and have established long-term relationships with the top 100 Life Sciences & Healthcare companies in the areas of pharmaceuticals, medical devices, biotechnology, animal health, clinical trial, health tech, cosmetics, agriculture and food, including most of the top 20 global pharmaceutical companies and nine out of the top ten global medical device companies. Our Life Sciences & Healthcare teams in Central and Eastern Europe advise leading global business groups in the sector on transactions, commercial agreements, regulatory matters, compliance, anti-counterfeiting, investigations and litigation, very often across multiple jurisdictions in the region and beyond. We can help you to navigate the regulatory landscape and to ensure compliance with both local laws and global policies.

With over 150 international specialist lawyers across CMS and the support of the Life Sciences Asia-Pacific Network (LAN), we understand the scientific and commercial as well as the legal imperatives affecting your Life Sciences & Healthcare business. Our experts, many of whom have worked in-house in your sector, have developed a shared capability in the areas of pharmaceuticals, biotechnology, medical devices and diagnostics. With active memberships in major industry associations such as the ABPI, ABHI, BIVDA, PAGB, EUCOMED and EFPIA, we help shape the legal frameworks impacting the Life Sciences & Healthcare sector. We regularly advise our clients on their day-to-day operational needs, providing support with advertisement and promotion of medicines, public sector procurement, pricing and reimbursement, patent enforcement and commercial and clinical trial agreements, as well as regulatory advice.


Feed

17/09/2021
Vac­cine com­pens­a­tion re­gimes in Ukraine
1. Are COV­ID-19 vac­cin­a­tions ob­lig­at­ory in your jur­is­dic­tion? Are you ex­pect­ing any le­gis­lat­ive changes to en­able man­dat­ory vac­cines for all or cer­tain people (e.g. health­care pro­fes­sion­als, pub­lic ser­vants...
Comparable
16/09/2021
Ukraine par­lia­ment launches his­tor­ic re­vi­sion of phar­ma­ceut­ic­al le­gis­la­tion
On 9 Septem­ber 2021, the Ukrain­i­an par­lia­ment sup­por­ted in the first read­ing a re­vi­sion of its le­gis­la­tion on medi­cines, ini­ti­at­ing a two-week peri­od for sub­mit­ting amend­ments to the ba­sic ver­sion. Sev­er­al...
14/09/2021
Le­gis­lat­ive frame­works to com­bat il­li­cit trade in med­ic­al products in Ukraine
1. What le­gis­lat­ive frame­work is there to com­bat il­li­cit trad­ing and oth­er il­leg­al activ­it­ies in coun­ter­feited/fals­i­fied/di­ver­ted medi­cines in your jur­is­dic­tion? The Ukrain­i­an leg­al frame­work aimed at...
Comparable
16/08/2021
Ukraine MoH pro­poses loosen­ing reg­u­la­tions on can­nabin­oids cir­cu­la­tion
In Ju­ly 2021, the Min­istry of Health of Ukraine (MoH) pub­lished for pub­lic dis­cus­sion a draft gov­ern­ment­al res­ol­u­tion (Draft) amend­ing Res­ol­u­tion No. 770 dated 6 May 2000 that lists the sched­ules of con­trolled...
09/08/2021
Ukraine changes qual­ity con­trol rules for im­por­ted medi­cines
On 21 Ju­ly 2021 the Cab­in­et of Min­is­ters of Ukraine amended its Res­ol­u­tion No. 902 On State Qual­ity Con­trol of Im­por­ted Medi­cines. The amend­ments took ef­fect on 27 Ju­ly 2021. The key points con­tained...
09/07/2021
Ukrain­i­an gov­ern­ment is plan­ning to in­tro­duce new pro­ced­ures for trade­mark...
Fol­low­ing the le­gis­lat­ive amend­ments re­lated inter alia to the reg­u­la­tion of trade­mark re­gis­tra­tion and pro­tec­tion ad­op­ted with­in the IP pat­ent re­form in 2020, the gov­ern­ment is now mov­ing for­ward with...
02/07/2021
Got your COV­ID-19 cer­ti­fic­ate?
Last week the Min­istry of Health of Ukraine (MoH) an­nounced that any in­di­vidu­al who has been fully vac­cin­ated against COV­ID-19 in Ukraine can ob­tain an in­ter­na­tion­al vac­cin­a­tion cer­ti­fic­ate. In a view...
25/06/2021
Double pat­ent­ing: leg­al fact or fic­tion? (G4/19)
The En­larged Board of Ap­peal (EBA) has this week re­leased its de­cision re­gard­ing the is­sue of double pat­ent­ing. The concept of double pat­ent­ing will be fa­mil­i­ar to those work­ing in the pat­ent field. It...
15/06/2021
New GDPR Code of Con­duct ap­proved for Cloud In­fra­struc­ture Ser­vice Pro­viders
The European Data Pro­tec­tion Board (EDPB) and the French Data Pro­tec­tion Au­thor­ity (CNIL) ap­proved the CISPE Data Pro­tec­tion Code of Con­duct of Cloud In­fra­struc­ture Ser­vice Pro­viders in Europe (CISPE...
08/06/2021
Trade secrets in Ukraine
Gen­er­al 1. Has the Dir­ect­ive (EU) 2016/943 of the European Par­lia­ment and of the Coun­cil of 8 June 2016 on the pro­tec­tion of un­dis­closed know-how and busi­ness in­form­a­tion (trade secrets) against their...
Comparable
04/06/2021
On the Pulse
Wel­come to CMS ‘On the Pulse’ video/pod­cast series for all Life Sci­ences & Health­care law­yers
01/06/2021
Some leaks can­'t be fixed
“Con­fid­en­tial in­form­a­tion is like an ice cube... give it to the party who has no re­fri­ger­at­or or will not agree to keep it in one, and by the time of the tri­al you have just a pool of wa­ter.” This...